Androgens and poor responders: are we ready to take the plunge into clinical therapy?

Fertil Steril. 2011 Nov;96(5):1062-5. doi: 10.1016/j.fertnstert.2011.09.050.

Abstract

Objective: To review and summarize data from the scientific literature on the use of androgens to improve ovarian function.

Design: Review of pertinent literature.

Setting: University hospital.

Patient(s): Women exposed to androgens.

Intervention(s): None.

Main outcome measure(s): Critical review of the literature.

Result(s): The artificial increase of intra-ovarian androgen concentrations constitutes an attractive concept for improving the deficient ovarian function of poor responders. Data from studies conducted in animals treated with high-dose androgens, together with observations made in hyperandrogenic women or female-to-male transsexuals receiving virilizing androgen doses, indicate that androgens may increase follicle responsiveness to FSH and/or the number of growing follicles in the ovary. Yet, definite clinical demonstration of such a concept still is not available.

Conclusion(s): Current clinical approaches aiming at increasing androgen availability in the ovary showed conflicting results. Therefore, additional studies using proper strategies to achieving higher intra-ovarian androgen concentrations for longer intervals are required to define the clinical efficiency of androgens in poor responders.

Publication types

  • Review

MeSH terms

  • Androgens / therapeutic use*
  • Animals
  • Female
  • Fertility Agents, Female / therapeutic use*
  • Gender-Affirming Procedures
  • Humans
  • Hyperandrogenism / physiopathology
  • Infertility / physiopathology
  • Infertility / therapy*
  • Male
  • Ovarian Follicle / drug effects*
  • Ovarian Follicle / physiopathology
  • Ovulation / drug effects*
  • Ovulation Induction / methods*
  • Pregnancy
  • Transsexualism / physiopathology
  • Transsexualism / therapy
  • Treatment Failure
  • Virilism / physiopathology

Substances

  • Androgens
  • Fertility Agents, Female